Treatment Registry
TR-0687 ActiveRecorded September 2026

Compounded semaglutide

Sold by Options Medical Weight Loss · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

Initial payment · 12-month plan

$2,388

Monthly equivalent

$199

initial payment (12-month medication term), including required fees on record. The monthly equivalent is not a monthly bill. It combines the advertised medication rate with any recorded monthly membership and excludes one-time and annual fees. Renewal charges are not established by that figure. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Compounded Semaglutide (GLP-1) Injections, 12-month plan paid in full · recorded upfront charge for 12 months$2,388

Added from the figures recorded below.

Price

TermPer monthCharged today
Compounded Semaglutide (GLP-1) Injections, 12-month plan paid in full

“$199 (per month for a 12-month plan paid in full)”

Per month$199Charged today$2,388
Price sources
Visit Options Medical Weight Loss

We earn nothing from this link. It opens Options Medical Weight Loss's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyOptioRx, Columbus OH
CancellationWe have a 72 hour refund policy, as stated in our membership agreement.

Not yet checked: states, prescriber, membership and consult fee.

Recorded from optionsmedicalweightloss.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Physical clinic chain (multiple US locations) plus a 'Telehealth' nav option; homepage names 'semaglutide (Wegovy)' and 'tirzepatide (Zepbound)' explicitly and advertises a 'Tirzepatide Weight-Loss Program,' but the dedicated Tirzepatide medication page (/medications/trz/) 404s, so no tirzepatide price could be verified despite it clearly being offered. Site also runs a separate credit-based 'membership' system for general clinic services (unrelated dollar figures), distinct from the GLP-1 price found.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0687
Medication category
compounded semaglutide
Readings
1

Related records

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 372 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Options Medical Weight Loss — compounded semaglutide (TR-0687). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0687

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.